Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Stake Decreased by Littlejohn & Co. LLC

Littlejohn & Co. LLC trimmed its stake in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Free Report) by 8.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,113,120 shares of the company's stock after selling 789,678 shares during the quarter. Aveanna Healthcare makes up 21.4% of Littlejohn & Co. LLC's holdings, making the stock its 2nd biggest holding. Littlejohn & Co. LLC owned about 4.20% of Aveanna Healthcare worth $42,188,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also bought and sold shares of the company. Connor Clark & Lunn Investment Management Ltd. acquired a new stake in Aveanna Healthcare in the 3rd quarter valued at $817,000. Renaissance Technologies LLC raised its holdings in shares of Aveanna Healthcare by 155.8% in the second quarter. Renaissance Technologies LLC now owns 158,600 shares of the company's stock valued at $438,000 after purchasing an additional 96,600 shares during the last quarter. Acadian Asset Management LLC grew its holdings in shares of Aveanna Healthcare by 176.6% in the second quarter. Acadian Asset Management LLC now owns 81,275 shares of the company's stock valued at $222,000 after acquiring an additional 51,890 shares in the last quarter. Vanguard Group Inc. increased its position in shares of Aveanna Healthcare by 1.8% during the 1st quarter. Vanguard Group Inc. now owns 2,571,251 shares of the company's stock valued at $6,402,000 after purchasing an additional 44,970 shares during the last quarter. Finally, SG Americas Securities LLC bought a new position in Aveanna Healthcare during the third quarter valued at about $101,000. Institutional investors own 87.96% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on AVAH shares. UBS Group increased their target price on Aveanna Healthcare from $1.70 to $2.80 and gave the stock a "sell" rating in a research report on Friday, August 9th. Deutsche Bank Aktiengesellschaft increased their price objective on Aveanna Healthcare from $3.00 to $5.00 and gave the stock a "buy" rating in a report on Friday, August 9th. Finally, Royal Bank of Canada upped their target price on Aveanna Healthcare from $3.00 to $5.00 and gave the stock a "sector perform" rating in a report on Friday, August 9th.

Aveanna Healthcare Price Performance

Shares of AVAH stock traded down $0.12 during trading hours on Monday, reaching $5.72. 989,941 shares of the company traded hands, compared to its average volume of 201,337. The firm has a 50-day moving average price of $5.20 and a 200 day moving average price of $4.19. The company has a market cap of $1.11 billion, a P/E ratio of -17.18 and a beta of 2.13. Aveanna Healthcare Holdings Inc. has a 12-month low of $2.00 and a 12-month high of $6.19.

Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) last announced its quarterly earnings data on Thursday, November 7th. The company reported $0.02 EPS for the quarter, beating the consensus estimate of ($0.01) by $0.03. The business had revenue of $509.02 million during the quarter, compared to analysts' expectations of $495.80 million. During the same quarter in the previous year, the firm earned ($0.05) earnings per share. Sell-side analysts predict that Aveanna Healthcare Holdings Inc. will post -0.09 EPS for the current year.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.